| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-29 |
GENE |
denotes |
Multidrug resistance proteins |
| T1 |
33-51 |
DISEASE |
denotes |
tuberous sclerosis |
| T2 |
56-75 |
DISEASE |
denotes |
refractory epilepsy |
| T3 |
77-95 |
DISEASE |
denotes |
Tuberous sclerosis |
| T4 |
130-143 |
REG |
denotes |
characterized |
| T5 |
147-155 |
MPA |
denotes |
seizures |
| T6 |
165-175 |
NEGREG |
denotes |
refractory |
| T7 |
238-246 |
REG |
denotes |
involved |
| T8 |
250-265 |
MPA |
denotes |
drug resistance |
| T9 |
269-287 |
DISEASE |
denotes |
tuberous sclerosis |
| T10 |
313-318 |
GENE |
denotes |
MDR-1 |
| T11 |
320-340 |
GENE |
denotes |
multidrug resistance |
| T12 |
346-351 |
GENE |
denotes |
MRP-1 |
| T13 |
353-394 |
GENE |
denotes |
multidrug resistance-associated protein-1 |
| T14 |
400-406 |
REG |
denotes |
linked |
| T15 |
410-433 |
MPA |
denotes |
chemotherapy resistance |
| T16 |
463-475 |
REG |
denotes |
relationship |
| T17 |
484-521 |
MPA |
denotes |
refractoriness to antiepileptic drugs |
| T18 |
526-531 |
GENE |
denotes |
MDR-1 |
| T19 |
535-540 |
GENE |
denotes |
MRP-1 |
| T20 |
547-557 |
MPA |
denotes |
expression |
| T21 |
602-611 |
REG |
denotes |
described |
| T22 |
622-640 |
DISEASE |
denotes |
tuberous sclerosis |
| T23 |
646-665 |
DISEASE |
denotes |
refractory epilepsy |
| T24 |
671-680 |
MPA |
denotes |
expressed |
| T25 |
681-706 |
GENE |
denotes |
multidrug resistance gene |
| T26 |
708-713 |
GENE |
denotes |
MDR-1 |
| T27 |
718-729 |
CPA |
denotes |
tuber cells |
| T28 |
735-761 |
CPA |
denotes |
epileptogenic brain lesion |
| T29 |
808-818 |
MPA |
denotes |
expression |
| T30 |
822-827 |
GENE |
denotes |
MDR-1 |
| T31 |
832-837 |
GENE |
denotes |
MRP-1 |
| T32 |
845-874 |
CPA |
denotes |
epileptogenic cortical tubers |
| T33 |
908-926 |
DISEASE |
denotes |
tuberous sclerosis |
| T34 |
931-950 |
DISEASE |
denotes |
refractory epilepsy |
| T35 |
997-1002 |
GENE |
denotes |
MDR-1 |
| T36 |
1007-1012 |
GENE |
denotes |
MRP-1 |
| T37 |
1107-1112 |
GENE |
denotes |
MDR-1 |
| T38 |
1117-1122 |
GENE |
denotes |
MRP-1 |
| T39 |
1137-1145 |
POSREG |
denotes |
strongly |
| T40 |
1146-1160 |
MPA |
denotes |
immunoreactive |
| T41 |
1173-1186 |
CPA |
denotes |
balloon cells |
| T42 |
1188-1206 |
CPA |
denotes |
dysplastic neurons |
| T43 |
1208-1218 |
CPA |
denotes |
astrocytes |
| T44 |
1220-1236 |
CPA |
denotes |
microglial cells |
| T45 |
1247-1266 |
CPA |
denotes |
blood-brain vessels |
| T46 |
1275-1284 |
POSREG |
denotes |
extensive |
| T47 |
1285-1290 |
GENE |
denotes |
MDR-1 |
| T48 |
1291-1307 |
MPA |
denotes |
immunoreactivity |
| T49 |
1312-1320 |
REG |
denotes |
observed |
| T50 |
1346-1365 |
DISEASE |
denotes |
refractory epilepsy |
| T51 |
1379-1397 |
DISEASE |
denotes |
tuberous sclerosis |
| T52 |
1405-1415 |
REG |
denotes |
associated |
| T53 |
1416-1420 |
REG |
denotes |
with |
| T54 |
1425-1435 |
MPA |
denotes |
expression |
| T55 |
1444-1470 |
GENE |
denotes |
multidrug resistance MDR-1 |
| T56 |
1475-1480 |
GENE |
denotes |
MRP-1 |
| T57 |
1481-1493 |
MPA |
denotes |
transporters |
| T58 |
1497-1526 |
CPA |
denotes |
epileptogenic cortical tubers |
| R0 |
T3 |
T4 |
ThemeOf |
Tuberous sclerosis,characterized |
| R1 |
T5 |
T4 |
ThemeOf |
seizures,characterized |
| R10 |
T13 |
T14 |
ThemeOf |
multidrug resistance-associated protein-1,linked |
| R11 |
T15 |
T14 |
ThemeOf |
chemotherapy resistance,linked |
| R12 |
T17 |
T16 |
ThemeOf |
refractoriness to antiepileptic drugs,relationship |
| R13 |
T18 |
T16 |
ThemeOf |
MDR-1,relationship |
| R14 |
T18 |
T20 |
ThemeOf |
MDR-1,expression |
| R15 |
T19 |
T16 |
ThemeOf |
MRP-1,relationship |
| R16 |
T19 |
T20 |
ThemeOf |
MRP-1,expression |
| R17 |
T20 |
T16 |
ThemeOf |
expression,relationship |
| R18 |
T22 |
T21 |
ThemeOf |
tuberous sclerosis,described |
| R19 |
T22 |
T24 |
ThemeOf |
tuberous sclerosis,expressed |
| R2 |
T5 |
T6 |
ThemeOf |
seizures,refractory |
| R20 |
T23 |
T21 |
ThemeOf |
refractory epilepsy,described |
| R21 |
T23 |
T24 |
ThemeOf |
refractory epilepsy,expressed |
| R22 |
T25 |
T21 |
ThemeOf |
multidrug resistance gene,described |
| R23 |
T25 |
T24 |
ThemeOf |
multidrug resistance gene,expressed |
| R24 |
T25 |
T27 |
ThemeOf |
multidrug resistance gene,tuber cells |
| R25 |
T25 |
T28 |
ThemeOf |
multidrug resistance gene,epileptogenic brain lesion |
| R26 |
T26 |
T24 |
ThemeOf |
MDR-1,expressed |
| R27 |
T26 |
T27 |
ThemeOf |
MDR-1,tuber cells |
| R28 |
T26 |
T28 |
ThemeOf |
MDR-1,epileptogenic brain lesion |
| R29 |
T27 |
T24 |
ThemeOf |
tuber cells,expressed |
| R3 |
T6 |
T4 |
ThemeOf |
refractory,characterized |
| R30 |
T28 |
T24 |
ThemeOf |
epileptogenic brain lesion,expressed |
| R31 |
T30 |
T29 |
ThemeOf |
MDR-1,expression |
| R32 |
T30 |
T32 |
ThemeOf |
MDR-1,epileptogenic cortical tubers |
| R33 |
T31 |
T29 |
ThemeOf |
MRP-1,expression |
| R34 |
T31 |
T32 |
ThemeOf |
MRP-1,epileptogenic cortical tubers |
| R35 |
T32 |
T29 |
ThemeOf |
epileptogenic cortical tubers,expression |
| R36 |
T33 |
T29 |
ThemeOf |
tuberous sclerosis,expression |
| R37 |
T33 |
T32 |
ThemeOf |
tuberous sclerosis,epileptogenic cortical tubers |
| R38 |
T34 |
T29 |
ThemeOf |
refractory epilepsy,expression |
| R39 |
T37 |
T39 |
ThemeOf |
MDR-1,strongly |
| R4 |
T8 |
T7 |
ThemeOf |
drug resistance,involved |
| R40 |
T37 |
T40 |
ThemeOf |
MDR-1,immunoreactive |
| R41 |
T38 |
T39 |
ThemeOf |
MRP-1,strongly |
| R42 |
T38 |
T40 |
ThemeOf |
MRP-1,immunoreactive |
| R43 |
T40 |
T39 |
ThemeOf |
immunoreactive,strongly |
| R44 |
T41 |
T39 |
ThemeOf |
balloon cells,strongly |
| R45 |
T41 |
T40 |
ThemeOf |
balloon cells,immunoreactive |
| R46 |
T42 |
T39 |
ThemeOf |
dysplastic neurons,strongly |
| R47 |
T42 |
T40 |
ThemeOf |
dysplastic neurons,immunoreactive |
| R48 |
T43 |
T39 |
ThemeOf |
astrocytes,strongly |
| R49 |
T43 |
T40 |
ThemeOf |
astrocytes,immunoreactive |
| R5 |
T9 |
T7 |
ThemeOf |
tuberous sclerosis,involved |
| R50 |
T44 |
T39 |
ThemeOf |
microglial cells,strongly |
| R51 |
T44 |
T40 |
ThemeOf |
microglial cells,immunoreactive |
| R52 |
T45 |
T39 |
ThemeOf |
blood-brain vessels,strongly |
| R53 |
T45 |
T40 |
ThemeOf |
blood-brain vessels,immunoreactive |
| R54 |
T46 |
T49 |
ThemeOf |
extensive,observed |
| R55 |
T47 |
T46 |
ThemeOf |
MDR-1,extensive |
| R56 |
T47 |
T48 |
ThemeOf |
MDR-1,immunoreactivity |
| R57 |
T47 |
T49 |
ThemeOf |
MDR-1,observed |
| R58 |
T48 |
T46 |
ThemeOf |
immunoreactivity,extensive |
| R59 |
T48 |
T49 |
ThemeOf |
immunoreactivity,observed |
| R6 |
T9 |
T8 |
ThemeOf |
tuberous sclerosis,drug resistance |
| R60 |
T50 |
T52 |
ThemeOf |
refractory epilepsy,associated |
| R61 |
T50 |
T53 |
ThemeOf |
refractory epilepsy,with |
| R62 |
T51 |
T52 |
ThemeOf |
tuberous sclerosis,associated |
| R63 |
T51 |
T53 |
ThemeOf |
tuberous sclerosis,with |
| R64 |
T54 |
T52 |
ThemeOf |
expression,associated |
| R65 |
T54 |
T53 |
ThemeOf |
expression,with |
| R66 |
T55 |
T52 |
ThemeOf |
multidrug resistance MDR-1,associated |
| R67 |
T55 |
T53 |
ThemeOf |
multidrug resistance MDR-1,with |
| R68 |
T55 |
T54 |
ThemeOf |
multidrug resistance MDR-1,expression |
| R69 |
T55 |
T57 |
ThemeOf |
multidrug resistance MDR-1,transporters |
| R7 |
T10 |
T14 |
ThemeOf |
MDR-1,linked |
| R70 |
T55 |
T58 |
ThemeOf |
multidrug resistance MDR-1,epileptogenic cortical tubers |
| R71 |
T56 |
T53 |
ThemeOf |
MRP-1,with |
| R72 |
T56 |
T54 |
ThemeOf |
MRP-1,expression |
| R73 |
T56 |
T57 |
ThemeOf |
MRP-1,transporters |
| R74 |
T56 |
T58 |
ThemeOf |
MRP-1,epileptogenic cortical tubers |
| R75 |
T57 |
T52 |
ThemeOf |
transporters,associated |
| R76 |
T57 |
T53 |
ThemeOf |
transporters,with |
| R77 |
T57 |
T54 |
ThemeOf |
transporters,expression |
| R78 |
T58 |
T57 |
ThemeOf |
epileptogenic cortical tubers,transporters |
| R79 |
T58 |
T52 |
ThemeOf |
epileptogenic cortical tubers,associated |
| R8 |
T11 |
T14 |
ThemeOf |
multidrug resistance,linked |
| R80 |
T58 |
T53 |
ThemeOf |
epileptogenic cortical tubers,with |
| R81 |
T58 |
T54 |
ThemeOf |
epileptogenic cortical tubers,expression |
| R9 |
T12 |
T14 |
ThemeOf |
MRP-1,linked |
